Negative regulation of NF-κB p65 activity by serine 536 phosphorylation

Science Signaling

Volumn 9, Issue 442, 2016, Pages

  Pradère, Jean Philippe ^a   Hernandez, Céline ^a   Koppe, Christiane ^b   Friedman, Richard A ^a   Luedde, Tom ^b   Schwabe, Robert F ^a  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LIPOPOLYSACCHARIDE; SERINE; TRANSCRIPTION FACTOR RELA; RELA PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; GENE; GENE EXPRESSION; HUMAN; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; INFLAMMATION; METABOLISM; MISSENSE MUTATION; PHOSPHORYLATION; TRANSGENIC MOUSE;

AMINO ACID SUBSTITUTION; ANIMALS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE, TRANSGENIC; MUTATION, MISSENSE; PHOSPHORYLATION; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 84983509269     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aab2820     Document Type: Article

References (42)

1. H. L. Pahl, Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866 (1999).
2. M. Karin, Y. Ben-Neriah, Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663 (2000).
3. F. Liu, Y. Xia, A. S. Parker, I. M. Verma, IKK biology. Immunol. Rev. 246, 239-253 (2012).
4. F. Mercurio, B. W. Murray, A. Shevchenko, B. L. Bennett, D. B. Young, J. W. Li, G. Pascual, A. Motiwala, H. Zhu, M. Mann, A. M. Manning, IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19, 1526-1538 (1999).
5. M. Hibi, A. Lin, T. Smeal, A. Minden, M. Karin, Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148 (1993).
6. M. L. Schmitz, I. Mattioli, H. Buss, M. Kracht, NF-κB: A multifaceted transcription factor regulated at several levels. Chembiochem 5, 1348-1358 (2004).
7. B. Huang, X.-D. Yang, A. Lamb, L.-F. Chen, Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway. Cell. Signal. 22, 1282-1290 (2010).
8. M. S. Hayden, S. Ghosh, NF-κB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev. 26, 203-234 (2012).
9. S. Ghosh, M. Karin, Missing pieces in the NF-κB puzzle. Cell 109 (suppl. 1), S81-S96 (2002).
10. H. Sakurai, H. Chiba, H. Miyoshi, T. Sugita, W. Toriumi, IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356 (1999).
11. T. Okazaki, S. Sakon, T. Sasazuki, H. Sakurai, T. Doi, H. Yagita, K. Okumura, H. Nakano, Phosphorylation of serine 276 is essential for p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300, 807-812 (2003).
12. J. Dong, E. Jimi, H. Zhong, M. S. Hayden, S. Ghosh, Repression of gene expression by unphosphorylated NF-κB p65 through epigenetic mechanisms. Genes Dev. 22, 1159-1173 (2008).
13. L. V. Madrid, M. W. Mayo, J. Y. Reuther, A. S. Baldwin Jr., Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940 (2001).
14. A. M. O'Mahony, M. Montano, K. Van Beneden, L.- F. Chen, W. C. Greene, Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1- mediated phosphorylation of RelA/p65. J. Biol. Chem. 279, 18137-18145 (2004).
15. F. Yang, E. Tang, K. Guan, C.-Y. Wang, IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170, 5630-5635 (2003).
16. C. Y. Sasaki, T. J. Barberi, P. Ghosh, D. L. Longo, Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway. J. Biol. Chem. 280, 34538-34547 (2005).
17. M. Adli, A. S. Baldwin, IKK-i/IKK∈ controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281, 26976-26984 (2006).
18. A. Douillette, A. Bibeau-Poirier, S.-P. Gravel, J.-F. Clément, V. Chénard, P. Moreau, M. J. Servant, The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IκB kinase complex. J. Biol. Chem. 281, 13275-13284 (2006).
19. A. U. Ahmed, S. T. Sarvestani, M. P. Gantier, B. R. G. Williams, G. E. Hannigan, Integrin-linked kinase modulates lipopolysaccharide- and Helicobacter pylori-induced nuclear factor κB-activated tumor necrosis factor-α production via regulation of p65 serine 536 phosphorylation. J. Biol. Chem. 289, 27776-27793 (2014).
20. J. Bohuslav, L.-f. Chen, H. Kwon, Y. Mu, W. C. Greene, p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279, 26115-26125 (2004).
21. 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 136, 2334-2344.e1 (2009).
22. A. Moles, A. M. Sanchez, P. S. Banks, L. B. Murphy, S. Luli, L. Borthwick, A. Fisher, S. O'Reilly, J. M. van Laar, S. A. White, N. D. Perkins, A. D. Burt, D. A. Mann, F. Oakley, Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology 57, 817-828 (2013).
23. H. Takeuchi, T. Hirano, S. E. Whitmore, I. Morisaki, A. Amano, R. J. Lamont, The serine phosphatase SerB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-κB RelA/p65. PLOS Pathog. 9, e1003326 (2013).
24. A. Lamb, X.-D. Yang, Y.-H. N. Tsang, J.-D. Li, H. Higashi, M. Hatakeyama, R. M. Peek, S. R. Blanke, L.-F. Chen, Helicobacter pylori CagA activates NF-κB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 10, 1242-1249 (2009).
25. 2+/calmodulindependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation. Mol. Cell. Biol. 34, 325-334 (2014).
26. Y.-J. Song, K.-Y. Jen, V. Soni, E. Kieff, E. Cahir-McFarland, IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 103, 2689-2694 (2006).
27. I. Mattioli, A. Sebald, C. Bucher, R.-P. Charles, H. Nakano, T. Doi, M. Kracht, M. L. Schmitz, Transient and selective NF-κB p65 serine 536 phosphorylation induced by T cell costimulation is mediated by IκB kinase β and controls the kinetics of p65 nuclear import. J. Immunol. 172, 6336-6344 (2004).
28. A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh, D. Baltimore, Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995).
29. M. Grove, M. Plumb, C/EBP, NF-κB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol. Cell. Biol. 13, 5276-5289 (1993).
30. J.-P. Pradere, J. Kluwe, S. De Minicis, J.-J. Jiao, G.-Y. Gwak, D. H. Dapito, M.-K. Jang, N. D. Guenther, I. Mederacke, R. Friedman, A.-C. Dragomir, C. Aloman, R. F. Schwabe, Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58, 1461-1473 (2013).
31. S. Ohno, H.-J. Im, C. B. Knudson, W. Knudson, Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFκB and p38 MAP kinase in articular chondrocytes. J. Biol. Chem. 281, 17952-17960 (2006).
32. C. Sauter, C. Wolfensberger, Interferon in human serum after injection of endotoxin. Lancet 316, 852-853 (1980).
33. T. Lawrence, M. Bebien, G. Y. Liu, V. Nizet, M. Karin, IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005).
34. Y. Wang, L. Hu, X. Tong, X. Ye, Casein kinase 1γ1 inhibits the RIG-I/TLR signaling pathway through phosphorylating p65 and promoting its degradation. J. Immunol. 192, 1855-1861 (2014).
35. R. F. Schwabe, H. Sakurai, IKKβ phosphorylates p65 at S468 in transactivaton domain 2. FASEB J. 19, 1758-1760 (2005).
36. H. Buss, A. Dörrie, M. L. Schmitz, R. Frank, M. Livingstone, K. Resch, M. Kracht, Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J. Biol. Chem. 279, 49571-49574 (2004).
37. T. Hunter, M. Karin, The regulation of transcription by phosphorylation. Cell 70, 375-387 (1992).
38. A. J. Whitmarsh, R. J. Davis, Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci. 57, 1172-1183 (2000).
39. P. Wang, P.-P. Guan, T. Wang, X. Yu, J.-J. Guo, Z.-Y. Wang, Aggravation of Alzheimer's disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells. Aging Cell 13, 605-615 (2014).
40. 536 phosphorylation. Diabetes 60, 1907-1916 (2011).
41. H. Geng, T. Wittwer, O. Dittrich-Breiholz, M. Kracht, M. L. Schmitz, Phosphorylation of NF-κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep. 10, 381-386 (2009).
42. D. H. Dapito, A. Mencin, G.-Y. Gwak, J.-P. Pradere, M.-K. Jang, I. Mederacke, J. M. Caviglia, H. Khiabanian, A. Adeyemi, R. Bataller, J. H. Lefkowitch, M. Bower, R. Friedman, R. B. Sartor, R. Rabadan, R. F. Schwabe, Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012).